👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
All content for Inside Lyme Podcast with Dr. Daniel Cameron is the property of Dr. Daniel Cameron and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
I take an “early aggressive” treatment approach to Lyme disease
Inside Lyme Podcast with Dr. Daniel Cameron
8 minutes
1 year ago
I take an “early aggressive” treatment approach to Lyme disease
When I first began treating Lyme disease, I adopted an “escalation” approach. This method involved starting with a standard course of doxycycline, typically lasting a month, and then observing how the patient responded. If the symptoms persisted or if I suspected that a co-infection might be present, I would escalate the treatment—adding or changing medications as needed. This approach was cautious and reactive, focusing on adjusting the treatment plan based on the patient’s progress over tim...
Inside Lyme Podcast with Dr. Daniel Cameron
👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
